Body Composition · INDIVIDUAL PEPTIDE
Tesamorelin
Tesamorelin is a GHRH analog FDA-approved to reduce visceral fat in a specific population. Prescription-only and clinician-supervised at Meto.
Quick Facts
The mechanism, in plain language.
Binds the GHRH receptor in the anterior pituitary to stimulate endogenous GH release. It's a stabilised native GHRH sequence with a specific track record in visceral adipose reduction — the RCTs supporting this are the strongest in the peptide literature.
How its administered
The dosing schedule below is the typical Meto starting protocol. Your clinician will adjust based on your labs, response and goal.
FORM & SOURCING
2 mg/vial lyophilised, reconstituted on arrival. Cold-chain shipping.
WHO ITS A FIT FOR
Who Benefits Most From This Protocol
Designed for adults looking to improve recovery, maintain lean muscle, and support healthy growth hormone function safely and strategically.
Adults with elevated visceral adiposity
Members wanting a GH-axis therapy with strong clinical evidence
GLP-1 patients plateaued on visceral fat specifically
Active malignancy or history of pituitary tumour
Uncontrolled diabetes or retinopathy
Pregnancy and lactation
What the literature says
Tesamorelin and visceral adipose tissue reduction in HIV
NEJM, 2010Tesamorelin off-label for NAFLD and metabolic syndrome
J. Clin. Endocrinol. Metab., 2023
Peptide Readiness Panel
The labs that pick your protocol.
IGF-1 sets your GH-axis baseline. hs-CRP flags inflammation that changes which peptides we'd choose. HbA1c and fasting insulin decide whether the muscle-preservation stack is safe for you. Drawn at a partner lab near you, or finger-prick kit to your door.
What you'll get
- Full panel results in your dashboard in 2–3 days
- Clinician interpretation in plain language
- Protocol match (P1–P4) with a confidence score
- Safety flags surfaced before any prescription
- HSA/FSA eligible · cancel anytime
Frequently Asked Questions
Tesamorelin vs. sermorelin?
Both are GHRH analogs. Tesamorelin is the native sequence stabilised for pharmaceutical use — it has the strongest RCT evidence in visceral fat. Sermorelin is the gentler entry point and is the GH-axis component of our Muscle Preservation and Comprehensive Support stacks.
Start with labs.
We won't prescribe Tesamorelin without reviewing your baseline labs first. The $149 Peptide Readiness Panel covers what your clinician needs to write a safe, individualised prescription.